Investor Database — 54,000+ VC, PE & angel contacts, the full list for $19.Get the list

Shenzhen Sanhang Venture Capital Co., Ltd.

Venture Capital Guangdong, China ·Founded 2012

Overview

Shenzhen Sanhang Venture Capital Co., Ltd. is a prominent venture capital firm based in Shenzhen, China, focusing on investments in the healthcare and life sciences sectors. The firm primarily targets startups in biotech, biopharma, medical devices, and digital health, aiming to support innovative companies with high growth potential. Established in 2012, Sanhang Venture Capital has expanded its presence with offices in Beijing, Suzhou, and Chicago, reflecting its commitment to fostering global partnerships. The firm's investment strategy emphasizes identifying promising startups that can achieve substantial returns and assisting them in reaching their full potential. With a team comprising industry experts, scientists, investors, and advisors, Sanhang Venture Capital manages a series of RMB and USD funds. The firm has been recognized with multiple awards from national organizations, underscoring its significant impact in the venture capital landscape.

Investment Focus

Innovative technologies
High growth potential
Strong management team

Portfolio Companies

SIA Intelligent TechnologySinovatio索元生物

Reach Shenzhen Sanhang Venture Capital Co., Ltd. directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Shenzhen Sanhang Venture Capital Co., Ltd.

What sectors does Shenzhen Sanhang Venture Capital Co., Ltd. invest in?

Shenzhen Sanhang Venture Capital Co., Ltd. invests in Digital Health, Medical Devices, Biotech and Biopharma, and is based in Guangdong, China. Shenzhen Sanhang Venture Capital Co., Ltd. is listed as a venture capital in the ConnectSafely investor database.

What stage does Shenzhen Sanhang Venture Capital Co., Ltd. invest at?

Shenzhen Sanhang Venture Capital Co., Ltd. backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.